FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+15.74%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$14.2B
AUM Growth
+$14.2B
(+4.8%)
Cap. Flow
+$68.9M
Cap. Flow
% of AUM
0.48%
Top 10 Holdings %
Top 10 Hldgs %
50.73%
Holding
123
New
26
Increased
36
Reduced
28
Closed
20
Top Buys
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
$393M |
| 2 |
Tilray
TLRY
|
$285M |
| 3 |
Equinix
EQIX
|
$263M |
| 4 |
Booking.com
BKNG
|
$254M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$207M |
Top Sells
| 1 |
Keurig Dr Pepper
KDP
|
$596M |
| 2 |
XL
XL Group Ltd.
XL
|
$407M |
| 3 |
LOGM
LogMein, Inc.
LOGM
|
$214M |
| 4 |
Gilead Sciences
GILD
|
$207M |
| 5 |
IQVIA
IQV
|
$136M |
Sector Composition
| 1 | Healthcare | 28.73% |
| 2 | Technology | 20.7% |
| 3 | Communication Services | 15.06% |
| 4 | Financials | 14.5% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
51
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $41.2M | 0.24% | 875,000 +131,500 | +18% | +$6.19M |
|
52
Grifois
GRFS
$6.78B
| $38.3M | 0.23% | 1,790,000 +1,238,696 | +225% | +$26.5M |
|
|
RC
53
Ready Capital
RC
$700M
| $36.7M | 0.22% | 2,203,239 -5,000 | -0.2% | -$83.3K |
|
|
RDUS
54
DELISTED
Radius Health, Inc.
RDUS
| $36.4M | 0.21% | 2,043,149 -2,043,151 | -50% | -$36.4M |
|
55
Sarepta Therapeutics
SRPT
$1.78B
| $31.5M | 0.19% | +195,000 | New | +$31.5M |
|
|
IDTI
56
DELISTED
Integrated Device Technology I
IDTI
| $30.1M | 0.18% | +640,000 | New | +$30.1M |
|
57
Savara
SVRA
$567M
| $27M | 0.16% | 2,418,009 +193,009 | +9% | +$2.15M |
|
58
AB InBev
BUD
$122B
| $25.7M | 0.15% | 293,109 -65,424 | -18% | -$5.73M |
|
59
Alnylam Pharmaceuticals
ALNY
$58.5B
| $24.2M | 0.14% | 276,551 -138,449 | -33% | -$12.1M |
|
|
TECX
60
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $24.1M | 0.14% | 465,000 +111,600 | +32% | +$5.79M |
|
61
Protagonist Therapeutics
PTGX
$3.67B
| $23.1M | 0.14% | 2,243,202 +1,332,973 | +146% | +$13.7M |
|
|
PGNX
62
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $22.7M | 0.13% | 3,612,820 +961,720 | +36% | +$6.03M |
|
63
Zymeworks
ZYME
$1.12B
| $21M | 0.12% | 1,335,000 +580,000 | +77% | +$9.11M |
|
64
PTC Therapeutics
PTCT
$3.92B
| $19.7M | 0.12% | +420,000 | New | +$19.7M |
|
|
APTX
65
DELISTED
Aptinyx Inc. Common Stock
APTX
| $19.4M | 0.11% | 670,000 +73,200 | +12% | +$2.12M |
|
66
Exelixis
EXEL
$10.1B
| $19.1M | 0.11% | +1,080,000 | New | +$19.1M |
|
67
Larimar Therapeutics
LRMR
$310M
| $19M | 0.11% | 1,625,000 +358,461 | +28% | +$4.19M |
|
68
Puma Biotechnology
PBYI
$254M
| $18.8M | 0.11% | +410,000 | New | +$18.8M |
|
69
Voyager Therapeutics
VYGR
$186M
| $17.2M | 0.1% | 909,158 +141,001 | +18% | +$2.67M |
|
70
Codexis
CDXS
$246M
| $17.2M | 0.1% | 1,000,000 -125,000 | -11% | -$2.14M |
|
|
BPY
71
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $16.6M | 0.1% | +794,382 | New | +$16.6M |
|
|
SHPG
72
DELISTED
Shire pic
SHPG
| $15.8M | 0.09% | 87,000 +17,453 | +25% | +$3.16M |
|
73
Intellia Therapeutics
NTLA
$1.22B
| $15.7M | 0.09% | 550,000 -290,000 | -35% | -$8.3M |
|
|
ZEAL
74
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $14.9M | 0.09% | 900,000 | – | – |
|
|
CCXI
75
DELISTED
ChemoCentryx, Inc.
CCXI
| $14.5M | 0.09% | 1,150,000 | – | – |
|